Thursday, 28 March 2024


Pharma industry expected to fragment

13 March 2012 | News | By Nandita Singh

"2012 will be the year when the pharma industry will begin to fragment rather than consolidate. The trend of companies breaking up R&D into smaller, leaner units and, in some cases, making them independent of the company will continue. I also predict it will spill over into smaller, leaner marketing and sales units at big pharma companies. This will set up the pharma industry for its eventual fate as a seller of drugs and devices innovated in start-up companies and smaller biotech companies. The effect of these changes will be continued growth in CROs - discovery, development and commercialization. This growth in CROs is inevitably accompanied by job losses in the pharma sector."

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account